Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-3002
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner ; volume:6 ; number:1 ; day:3 ; month:4 ; year:2018 ; pages:1-13 ; date:12.2018
Cancer & metabolism ; 6, Heft 1 (3.4.2018), 1-13, 12.2018
- Urheber
-
Viswanath, Pavithra
- Beteiligte Personen und Organisationen
-
Radoul, Marina
Izquierdo-Garcia, Jose Luis
Luchman, Hema Artee
Gregory Cairncross, J.
Pieper, Russell O.
Phillips, Joanna J.
Ronen, Sabrina M.
SpringerLink (Online service)
- DOI
-
10.1186/s40170-018-0178-3
- URN
-
urn:nbn:de:1111-201805164106
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Viswanath, Pavithra
- Radoul, Marina
- Izquierdo-Garcia, Jose Luis
- Luchman, Hema Artee
- Gregory Cairncross, J.
- Pieper, Russell O.
- Phillips, Joanna J.
- Ronen, Sabrina M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
IDH1-dependent chemical alterations in gliomas, and its implications for in situ optical diagnosis
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Therapies for IDH-Mutant Gliomas
Biostructural, biochemical and biophysical studies of mutant IDH1
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
IDH1-dependent chemical alterations in gliomas, and its implications for in situ optical diagnosis
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Therapies for IDH-Mutant Gliomas
Biostructural, biochemical and biophysical studies of mutant IDH1
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
IDH1-dependent chemical alterations in gliomas, and its implications for in situ optical diagnosis
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Therapies for IDH-Mutant Gliomas
Biostructural, biochemical and biophysical studies of mutant IDH1
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas